Breakfast Program: The Frustration Factor: Presbyopia in the Modern Age**

• This promotional educational event is presented by Allergan, an AbbVie company.
  George O. Waring IV MD, FACS; Karolinne Maia Rocha, MD, PhD; Christopher E. Starr, MD

Exhibit Hall Break

Opening Remarks
Richard L. Lindstrom, MD

Astigmatism Management: Toric IOLs and Limbal Relaxing Incisions
Moderator: John A. Hovanesian, MD, FACS

Introduction and Pretest

New Digital Tools to Drive Accuracy and Adoption in Refractive Cataract Surgery
John A. Hovanesian, MD, FACS

Immunomodulators for Better Refractive Outcomes in Dry Eye Patients
Alice T. Epitropoulos, MD

What to Do When the Astigmatic Axis varies with Different Pre-op Biometers
Uday Devgan, MD

Toric IOLs: What’s Out There?
Darrell E. White, MD

Astigmatism Enhancements After Cataract Surgery
John P. Berdahl, MD

Intraoperative Digital Marking: Do I Really Need This?
Nicole R. Fram, MD

Pinhole Pupilloplasty
Ashvin Agarwal, MS

Suture Fixation of Toric IOLs
Brandon D. Ayres, MD

Discussion and Posttest

Exhibit Hall Break

Retina
Moderator: Andrew A. Moshfeghi, MD, MBA

Introduction and Pretest

What’s New in the Treatment of Age-related Macular Degeneration?
Andrew A. Moshfeghi, MD, MBA

Pearls for the Anterior Segment Surgeon from the Retina Surgeon’s Perspective
Jorge A. Fortun, MD

Mathematical Concepts in Understanding Retinal Diseases
Darius M. Moshfeghi, MD

Break

CME Lunch Seminar: Medical Retina Update: Applying New Data to Practice
Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

IOLs and Lens-based Refractive Surgery
Moderator: Nicole R. Fram, MD

Introduction and Pretest
Nicole R. Fram, MD

Pearls for Selecting (or not selecting) the Best Presbyopia-correcting IOL for Your Patient
William B. Trattler, MD

Should I Look at Higher Order Aberrations and Why Does it Matter?
Karolinne M. Rocha, MD, PhD

Dysfunctional Lens Syndrome and ICLs
George O. Waring IV, MD, FACS

How do I Implement a New Technology Before I Really Know How It Works?
Mitchell P. Weikert, MD, MS

My Patient is Unhappy in the First Eye: What Should I Do?
Nicole R. Fram, MD

How to Handle Capsular Issues When a Premium IOL is Planned?
Uday Devgan, MD

Discussion, Q&A and Posttest

Exhibit Hall Break

Neuro-Opthalomogy Update
Five Neuro-opthalmologic Diagnoses You Cannot Afford to Miss
Andrew G. Lee, MD

Glaucoma
Moderator: Thomas W. Samuelson, MD

Introduction and Pretest

Case One: The Newly Diagnosed Glaucoma Patient
Thomas W. Samuelson, MD

The Case for SLT
Nathan M. Radcliffe, MD

The Case for Depot Drug Delivery
Sarah H. Van Tassel, MD

The Case for Eyedrop Therapy
Audience Volunteer & Panel Discussion

Panel Discussion

Case Two: Cataract and Mild Glaucoma
Thomas W. Samuelson, MD

The Case for Phaco plus Canal Stent Device
Sarah H. Van Tassel, MD

The Case for Phaco plus Segmental Goniotomy
Valerie Trubnik, MD, FACS

The Case for Phaco plus Combined Canal Dialation/Goniotomy
Manjool Shah, MD

Panel Discussion

Case Three: Cataract and Moderate to Severe Glaucoma
Thomas W. Samuelson, MD

The Case for Phaco plus Combined MIGS
Nathan M. Radcliffe, MD

The Case for Phaco plus Gel Stent
Valerie Trubnik, MD, FACS

The Case for Phaco plus Trab or Tube
Manjool Shah, MD

Panel Discussion and Postest

Glacuoma Hot Topics
Moderator: Thomas W. Samuelson, MD
Panelists: Nathan M. Radcliffe, MD; Manjool Shah, MD; Valerie Trubnik, MD, FACS; Sarah H. Van Tas-sel, MD

CME Breakfast Seminar: Mitigating Thyroid Eye Disease through Prompt Diagnosis and Treatment

• Supported by an educational grant from Horizon Therapeutics USA, Inc.
  Moderator: Gary J. Lelli Jr., MD
  Faculty: Prem S. Subramanian, MD, PhD

Introduction and Pre-test
Gary Lelli Jr., MD

Thyroid Eye Disease: Challenges in Diagnosis
Prem S. Subramanian, MD, PhD

• Etiology, pathogenesis, relevant risks and factors
• Difficult diagnosis due to heterogeneous signs and symptoms
• Use of imaging for detection

Case Presentation: Differential Diagnosis
Prem S. Subramanian, MD, PhD

Incorporating Best Practices for the Treatment of Thyroid Eye Disease
Gary Lelli Jr., MD

• Management during active phase versus stable
• Conventional use of steroids – benefits and limitations
• Use and safety considerations of newly approved biologic, teprotumumab
• Multidisciplinary care strategies

Case Presentation: Treatment of Thyroid Eye Disease
Gary Lelli Jr., MD

Post-test and Q&A

Opening Remarks

• Richard L. Lindstrom, MD

Practice Management
Moderator: Candace S. Simerson, FASOA, COE, CMPE

Ophthalmology Trends and Private Equity Penetration
Richard C. Edlow, OD

Coding Update
Mary Pat Johnson, COMT, CPC, COE, CPMA

Exhibit Hall Break

Corneal Health Roundtables: NSAIDs and Anti-infectives
Moderator: Eric D. Donnenfeld, MD
Panelists: Nicole R. Fram, MD; P. Dee Stephenson, MD, FACS, ABES, FSEE; William B. Trattler, MD; John A. Hovanesian, MD, FACS; Terry Kim, MD

CME Seminar: Navigating Emerging Approaches for the Treatment of nAMD and DME

• Supported by an educational grant from Genentech, a member of the Roche Group
  Moderator: Sophie J. Bakri, MD
  Faculty: Dilsher S. Dhoot, MD

Introduction and Pre-test
Sophie J. Bakri, MD

MOAs on the Move: Emerging Action in nAMD and DME Treatment
Dilsher S. Dhoot, MD

Review of current evidence pertaining to treatment burden and dosing regimens in nAMD, and DME.

Discussion of new and emerging therapeutics that offer extended duration with unique mechanisms and extended duration in nAMD and DME:

• Faricimab – bispecific for VEGF and Ang2, ability to maintain vascular stability – use inn AMD, DME — AVENUE, STAIRWAY, BOULEVARD, TENAYA, LUCERNE, RHINE, YOSEMITE
• KSI-301 and GB-102

Advances in Delivery for the Treatment of nAMD and DME
Sophie J. Bakri, MD

• Systems that deliver medication for extended periods of time – Refillable, rigid port delivery system (PDS), gene therapy, miniature pumps, bioerodible implants, suprachoroidal surgery
• Status of gene therapy – ADVM-022, RGX-314
• PDS with ranibizumab: Surgical techniques required, laser ablation, tips and tricks for surgery, avoiding complications, in-clinic refill

Updates on LADDER, ARCHWAY, Pagoda, PORTAL (extension study), and Pavilion

Post-test and Q&A

Corneal Health Roundtables: Dry Eye, Allergy and Anti-infectives
Moderator: Eric D. Donnenfeld, MD
Panelists: Kenneth R. Kenyon, MD; Henry “Hank” D. Perry, MD; Darrell E. White, MD; Cynthia Matossian, MD, FACS; Marguerite B. McDonald, MD, FACS; Elizabeth Yeu, MD

Closing Remarks and Lunch To Go